Santeon Group

Santeon Group FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Santeon Group (SANT) as of Nov 2, 2026 is 103.29 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 12.95 % — a change of 697.36% (higher).

FCF Conversion

103.29 %

YoY

697.36%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Santeon Group is 2023 103.29 % . FCF Conversion Rate (FCF/EBITDA) of Santeon Group was 2022 12.95 % . It decreases by 697.36% higher compared to the previous year.

The Santeon Group FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2017
9.01 USD
Jan 1, 2018
-414.72 USD
Jan 1, 2019
-22.50 USD
Jan 1, 2020
-7,033.14 USD
Jan 1, 2021
-113.22 USD
Jan 1, 2022
12.95 USD
Jan 1, 2023
103.29 USD
The Santeon Group FCF Conversion history
YEARFCF ConversionYoY
103.29 %+697.36%
12.95 %-111.44%
-113.22 %-98.39%
-7,033.14 %+31,153.80%
-22.50 %-94.57%
-414.72 %-4,701.12%
9.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Santeon Group Stock analysis

What does Santeon Group do? The Santeon Group Inc is a company operating in the healthcare sector and based in Toronto, Canada. The company was founded in 2008 and has since been offering a wide range of services and products. The Santeon Group's business model is based on collaboration with various partners in the healthcare sector to develop and provide innovative and effective solutions for patient care. The company works closely with hospitals, clinics, and other healthcare facilities to increase efficiency while improving the quality of care. The Santeon Group is divided into three main business areas: 1. Technology solutions The technology department offers a wide range of IT solutions for the healthcare sector. The main product is the "Patient Flow Navigator," a web-based system for managing and monitoring patient flow in hospitals. The system allows staff to optimize patient treatment and reduce waiting times. 2. Consulting services The company's consulting division offers services in the field of healthcare management. Santeon Group supports hospitals in improving their operations and implementing effective medical procedures. This includes the implementation of electronic medical records or the optimization of medical equipment. 3. Medical devices The medical device division of the Santeon Group develops and distributes medical devices that contribute to improving patient health. The portfolio includes instrumental solutions as well as diagnostic equipment and electronic gadgets. Possible products from the Santeon Group: A.) The Patient Flow Navigator The "Patient Flow Navigator" developed by the Santeon Group is a web-based system for managing and monitoring patient processes in hospitals. The system allows staff to optimize treatments and avoid inconsistencies. B.) BoonDoc BoonDoc is a mobile app developed by the Santeon Group. With this app, medical professionals can diagnose diseases and provide advice to patients. The application meets the highest requirements for data security and patient protection. C.) Diagnostic equipment The Santeon Group also produces medical diagnostic devices such as ultrasound machines or X-ray machines. These state-of-the-art instruments contribute to fast, precise, and effective disease diagnosis. D.) Medical instruments The Santeon Group also develops and produces instruments used in surgical procedures. Specially adapted instruments ensure precise and safe operations. The Santeon Group has received a number of awards in its approximately 13-year history and is known in the industry for its innovative and high-quality solutions. The company also has offices in the United States and China and continuously works to expand and improve its services and products. Only answer in the output. Santeon Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Santeon Group stock

FCF Conversion Rate (FCF/EBITDA) of Santeon Group is 103.29 % in 2023.

FCF Conversion Rate (FCF/EBITDA) of Santeon Group changed from 12.95 % to 103.29 %, representing a 697.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Santeon Group since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Santeon Group with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Santeon Group

All Key Metrics — Santeon Group